drugset / Trial / NCT05744674
Phase Ⅱ Study of Intercostal Nerve Block With HR18034 for Postsurgical Pain Management
RandomizedParallel-groupQuadruple-blindSupportive care
Summary
Phase Ⅱ, randomized, double-blind, comparator-controlled study to evaluate the efficacy, safety and pharmacokinetics of single injection intercostal nerve block with HR18034 for postoperative pain management compared with ropivacaine.
Timeline
- Start
- 2023-02-21
- Primary completion
- 2023-06-30
- Completion
- 2023-06-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | HR18034 | Unknown | 228 mg | Other |
| Subject | HR18034 | Unknown | 342 mg | Other |
| Subject | HR18034 | Unknown | 456 mg | Other |
| Comparator | Ropivacaine | Other / unclassified | 60 mg | Other |
| Comparator | Ropivacaine | Other / unclassified | 90 mg | Other |
| Comparator | Ropivacaine | Other / unclassified | 120 mg | Other |
Indications
No indication recorded.